Notice of alternative medication authorization, May 31, 2023

This notice was published on June 8, 2023.

• Prazosin hydrochloride, capsules, 0.5 mg replaces Teva-Prazosin, tablets, 1 mg
• Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
• Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
• Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg